← Leaderboards
Xuanyong Lu
Imcare Biotech, Inc.
$6,399,045
Attributed
$6,399,045
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.6M · FY2012–23$2M$1.5M$1M$500K$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$6,399,045 · 3
By mechanism
R44$5,939,857 · 1
R43$292,459 · 1
SB1$166,729 · 1
Top collaborators
No co-investigators on record.
Most similar at Imcare Biotech, Inc.
Same institution · by research overlap
- Bobby Kumar Biswal$364,763
Others in their field
Top investigators on “Specificity”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Eric S Lander · Whitehead Institute For Biomedical Res$527,312,131
- Barton F Haynes · Duke University$483,626,898
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$395,980,920
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$381,706,339
Research focus
SpecificityProteinsSensitivity And SpecificitySerumTechnologyMalignant Neoplasm Of LiverPhase 2 StudyPerformanceSerine Proteinase InhibitorsPrimary Carcinoma Of The Liver CellsLiver DiseasesSurvival RateLiver CirrhosisDiagnosisEarly DiagnosisMonoclonal AntibodiesClinical ResearchPancreatitisEnzyme-Linked Immunosorbent AssayBiological MarkersHigh RiskImaging TechnologyAlpha-FetoproteinsBase
Grant awards (9)
A novel diagnostic Kit for Hepatocellular Carcinoma$1,289,036
R44 · FY2023 · CA · contact PI
A novel diagnostic Kit for Hepatocellular Carcinoma$1,283,792
R44 · FY2022 · CA · contact PI
A novel diagnostic Kit for Hepatocellular Carcinoma$1,420,847
R44 · FY2021 · CA · contact PI
Comprehensive Intellectual Property, Reimbursement, and Licensing Strategy for ImCare Biotech's Diagnostic Product Seravue$166,729
SB1 · FY2021 · CA · contact PI
A novel diagnostic biomarker for Hepatocellular Carcinoma(HCC)$1,400
R44 · FY2018 · CA · contact PI
A novel diagnostic biomarker for Hepatocellular Carcinoma(HCC)$654,671
R44 · FY2017 · CA · contact PI
A novel diagnostic biomarker for Hepatocellular Carcinoma(HCC)$657,468
R44 · FY2016 · CA · contact PI
A novel diagnostic biomarker for Hepatocellular Carcinoma(HCC)$632,643
R44 · FY2015 · CA · contact PI
A novel diagnostic biomarker for hepatocellular carcinoma and cholangiocarcinoma$292,459
R43 · FY2012 · CA · contact PI